Verona Pharma Ownership | Who Owns Verona Pharma?
Verona Pharma Ownership Summary
Verona Pharma is owned by 3.34% institutional investors, 11.95% insiders, and 84.71% retail investors. Morgan stanley is the largest institutional shareholder, holding 1.07% of VRNA shares. Eventide Gilead N is the top mutual fund, with 2.22% of its assets in Verona Pharma shares.
VRNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Verona Pharma | 3.34% | 11.95% | 84.71% |
| Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
| Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Morgan stanley | 864.03K | 1.07% | $12.49M |
| Perceptive advisors | 6.56M | 0.97% | $416.71M |
| Nea management company | 5.58M | 0.86% | $259.36M |
| Bank of america corp /de/ | 611.02K | 0.76% | $8.84M |
| Darwin global management | 3.92M | 0.58% | $245.98M |
| Blackrock | 430.43K | 0.53% | $6.22M |
| Frazier life sciences management | 3.46M | 0.51% | $219.54M |
| Eventide asset management | 3.13M | 0.48% | $145.46M |
| Maverick capital | 3.13M | 0.48% | $145.29M |
| Wellington management group llp | 3.03M | 0.46% | $140.49M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 1.44M | 19.04% | $91.23M |
| Aisling capital management lp | 1.12M | 18.38% | $51.80M |
| Darwin global management | 3.92M | 16.81% | $245.98M |
| Perceptive advisors | 6.56M | 14.68% | $416.71M |
| Nea management company | 5.58M | 14.64% | $259.36M |
| Vivo capital | 2.28M | 11.88% | $106.07M |
| Frazier life sciences management | 3.46M | 10.03% | $219.54M |
| Artia global partners lp | 538.49K | 8.65% | $34.19M |
| Alerce investment management | 88.00K | 7.19% | $4.09M |
| Ctf capital management, lp | 236.77K | 6.22% | $11.00M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Darwin global management | 3.92M | 16.81% | 3.11M |
| Wellington management group llp | 3.03M | 0.03% | 1.15M |
| Rtw investments, lp | 2.85M | 2.77% | 1.03M |
| Point72 asset management | 711.01K | 0.07% | 711.01K |
| Eventide asset management | 3.13M | 2.65% | 706.28K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -2.86M |
| Carlyle group | - | - | -2.46M |
| Ra capital management | - | - | -1.77M |
| Vivo capital | 2.28M | 11.88% | -1.27M |
| Maverick capital | 3.13M | 2.61% | -1.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 711.01K | 0.07% | 711.01K | $33.02M |
| Ctf capital management, lp | 236.77K | 6.22% | 236.77K | $11.00M |
| Gw&k investment management | 232.35K | 0.09% | 232.35K | $10.79M |
| Baker bros. advisors lp | 223.84K | 0.16% | 223.84K | $14.21M |
| Balyasny asset management | 183.90K | 0.01% | 183.90K | $8.54M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -2.00 |
| Td private client wealth | -30.00 |
| Naples money management | -100.00 |
| National bank of canada /fi/ | -150.00 |
| Redwood wealth management group | -410.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 25 | -88.37% | 22,667,271 | -66.98% | 3 | 3.01% | 15 | -86.96% | 5 | -92.06% |
| Dec 31, 2024 | 201 | 23.31% | 61,094,145 | -9.72% | 9 | 0.14% | 106 | 23.26% | 61 | 22.00% |
| Sep 30, 2024 | 161 | 21.97% | 67,432,127 | 2.42% | 82 | 1.25% | 85 | 19.72% | 49 | 48.48% |
| Jun 30, 2024 | 131 | 11.97% | 65,836,577 | -1.14% | 81 | 1.16% | 70 | 18.64% | 33 | 22.22% |
| Mar 31, 2024 | 117 | -4.88% | 66,592,785 | -1.29% | 84 | 75.18% | 59 | -4.84% | 27 | -6.90% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Gilead N | 1.89M | 2.22% | - |
| T. Rowe Price Health Sciences | 1.36M | 1.60% | -8.06K |
| Bellevue Healthcare Ord | 1.10M | 1.36% | 1.10M |
| Eventide Healthcare & Life Sciences I | 988.17K | 1.16% | -241.83K |
| Janus Henderson Global Life Sciences D | 952.49K | 1.12% | 190.90K |
| Polar Capital Biotech S Inc | 875.00K | 1.03% | 125.00K |
| Hood River Small-Cap Growth Instl | 838.91K | 0.99% | - |
| Janus Henderson Glb Life Scn I2 USD | 828.57K | 0.98% | 62.39K |
| Federated Hermes Kaufmann Small Cap A | 777.40K | 0.91% | -161.10K |
| Federated Hermes Kaufmann Small Cap Grow | 777.40K | 0.91% | -161.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 16, 2025 | Fisher Andrew | General Counsel | Sell | $922.00K |
| Jun 11, 2025 | Hahn Mark W | Chief Financial Officer | Sell | $4.56M |
| Jun 11, 2025 | ZACCARDELLI DAVID | President and CEO | Sell | $4.56M |
| May 28, 2025 | Hahn Mark W | Chief Financial Officer | Sell | $1.51M |
| May 27, 2025 | Hahn Mark W | Chief Financial Officer | Sell | $308.98K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | 26 |
| 2025 Q1 | - | 1 |
| 2024 Q4 | 3 | 33 |
| 2024 Q3 | 1 | 8 |
VRNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools